Related references
Note: Only part of the references are listed.Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells
Mi-Young Son et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The dipeptidyl peptidase IV family in cancer and cell biology
Denise M. T. Yu et al.
FEBS JOURNAL (2010)
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy
C. Lu et al.
ONCOGENE (2010)
Calcium dysregulation induces apoptosis-inducing factor release: Cross-talk between PARP-1-and calpain- signaling pathways
Peter S. Vosler et al.
EXPERIMENTAL NEUROLOGY (2009)
Dipeptidyl peptidase 8 and 9-guilty by association?
Melissa R. Pitman et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
DPP4 inhibitors for diabetes-What next?
Anne-Marie Lambeir et al.
BIOCHEMICAL PHARMACOLOGY (2008)
A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature
Jeffrey D. Hancock et al.
CELL CYCLE (2008)
High expression of neuropeptide Y1 receptors in Ewing sarcoma tumors
Meike Koerner et al.
CLINICAL CANCER RESEARCH (2008)
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future
Joseph A. Ludwig
CURRENT OPINION IN ONCOLOGY (2008)
Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8
Katerina Ajami et al.
FEBS LETTERS (2008)
The role of CD26/dipeptidyl peptidase IV in cancer
Pamela A. Havre et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Microsatellites as EWIS/FLI response elements in Ewing's sarcoma
Kunal Gangwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates
Pieter Van der Veken et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
AIF-mediated programmed necrosis - A highly regulated way to die
Hanan Boujrad et al.
CELL CYCLE (2007)
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer
Kalyani Narra et al.
CANCER BIOLOGY & THERAPY (2007)
Talabostat
Charles Casey Cunningham
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Dipeptidyl peptidase 8/9-like activity in human leukocytes
Marie-Berthe Maes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Neuropeptide Y (NPY) cleaving enzymes:: Structural and functional homologues of dipeptidyl peptidase 4
Nadine Frerker et al.
PEPTIDES (2007)
Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV
Jais R. Bjelke et al.
BIOCHEMICAL JOURNAL (2006)
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Richard Smith et al.
CANCER CELL (2006)
Apoptosis-inducing factor: vital and lethal
Nazanine Modjtahedi et al.
TRENDS IN CELL BIOLOGY (2006)
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity
CY Edosada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mitochondrial targeting signal in human neuropeptide Y gene
K Kaipio et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC
AP Silva et al.
BIOLOGY OF THE CELL (2005)
Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α
K Aertgeerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors
J Kitlinska et al.
CANCER RESEARCH (2005)
Fibroblast activation protein-α and dipeptidyl peptidase IV (CD26):: Cell-surface proteases that activate cell signaling and are potential targets for cancer therapy
T Kelly
DRUG RESISTANCE UPDATES (2005)
Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer
P Busek et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
PT-100, a small molecule dipeptidyl peptidase inhibitorg has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism
S Adams et al.
CANCER RESEARCH (2004)
Neuropeptide Y induces ischemic angiogenesis and restores fimction of ischemic skeletal muscles
EW Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells
A Üren et al.
ONCOGENE (2003)
Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation
AAP Zada et al.
ONCOGENE (2003)
Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells:: modulation of intracellular calcium
D Jacques et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
The multifunctional or moonlighting protein CD26/DPPIV
E Boonacker et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2003)
Mitogenic actions of neuropeptide Y in vascular smooth muscle cells:: synergetic interactions with the β-adrenergic system
J Pons et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
SW Yu et al.
SCIENCE (2002)
Predominant role by CaM kinase in NPYY1 receptor signaling: Involvement of CREB and ambikaipakan
S Sheriff et al.
PEPTIDES (2002)
Neuropeptide Y functions as a neuroproliferative factor
DE Hansel et al.
NATURE (2001)
Share Paper
